Medacta Group SA (LON:0A05)

London flag London · Delayed Price · Currency is GBP · Price in CHF
133.10
+0.02 (0.01%)
At close: Apr 30, 2025
Market Cap 2.39B
Revenue (ttm) 488.39M
Net Income (ttm) 60.27M
Shares Out n/a
EPS (ttm) 3.02
PE Ratio 39.59
Forward PE n/a
Dividend 0.48 (0.37%)
Ex-Dividend Date May 9, 2025
Volume 2,662
Average Volume 2,285
Open 132.00
Previous Close 133.08
Day's Range 131.60 - 133.40
52-Week Range 95.70 - 134.80
Beta 1.19
RSI 60.99
Earnings Date Sep 8, 2025

About Medacta Group

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland. [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1958
Employees 1,907
Stock Exchange London Stock Exchange
Ticker Symbol 0A05
Full Company Profile

Financial Performance

In 2024, Medacta Group's revenue was 590.58 million, an increase of 15.62% compared to the previous year's 510.78 million. Earnings were 72.89 million, an increase of 53.89%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.